Wise Will Seek FDA Approval for Digital Anxiety Management Therapy

May 17, 2021, 12:00 AM

Multiple Sclerosis News Today’s columnist, Jenn Powell, discusses FDA approval for Wise’s digital anxiety management therapy.
Also, columnist Jessie Ace reads a column by Jennifer Powell where she describes how her new role of being the caregiver in her relationship makes her feel.
=====================================
Treatment for Relapsing MS Progression | MAYZENT® (siponimod)
Read about MAYZENT, a once daily pill that can significantly slow down disability progression in people with relapsing MS. See full prescribing & safety info.
=====================================
Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
=====================================
To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/